Literature DB >> 12756510

Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo.

Hervé Allain1, Danièle Bentué-Ferrer, Antoine Tarral, Jean-Marc Gandon.   

Abstract

OBJECTIVE: In elderly patients, both falls and impaired memory are considerable medical problems. Hypnotics, which are frequently administered to this patient group for the treatment of insomnia, should ideally not impair equilibrium or memory functions. This double-blind, randomised, four-way, cross-over study investigated the effects of frequently prescribed hypnotics from different classes on postural oscillation and memory under real life conditions. Zolpidem 5 mg, zopiclone 3.75 mg, lormetazepam 1 mg (i.e. usual starting doses in elderly) or placebo were administered at night to 48 healthy elderly volunteers aged 65 years or more. The study included four treatment periods separated by wash-out periods of at least 1 week.
METHODS: Psychomotor tests up to 9 h or 10 h after drug intake included, for attention and body sway, clinical stabilometric platform (CSP) tests, simple reaction time (SRT), and the critical tracking test (CTT); for memory, the learning memory tasks (LMT) and the Sternberg memory scanning test (mean reaction time [MRT] and percentage of correct answers) were used. For subjective sleep evaluation the Leeds sleep evaluation questionnaire (LSEQ) and for sedation a visual analogue scale (VAS) were used. For safety evaluations, adverse events (AEs) were recorded.
RESULTS: The results demonstrate that compared with placebo, the active drugs increased body sway (area eyes open and closed in the CSP); however, this effect disappeared after 5 h with zolpidem, while it disappeared only after 8 h with lormetazepam and zopiclone. All three drugs did not affect attention assessed by the SRT and CTT. Concerning memory, Sternberg MRT at 9 h was not significantly different up to 5 digits for all groups in comparison with placebo, while for 6 digits it was significantly increased with lormetazepam and zopiclone. In the LMT, an impairment of performance was observed with lormetazepam relative to both zolpidem and placebo.
CONCLUSION: The safest compared drug with regard to body sway was zolpidem, because of its short-lasting effect. In addition, zolpidem did not show any significant effect on memory functions, in the present dose comparison.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12756510     DOI: 10.1007/s00228-003-0591-5

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  31 in total

1.  Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics.

Authors:  H Allain; A Patat; A Lieury; F Le Coz; C Janus; G Menard; J Gandon
Journal:  Eur Psychiatry       Date:  1995       Impact factor: 5.361

Review 2.  Hypnotics and behavior.

Authors:  T Roth; T A Roehrs; E J Stepanski; L D Rosenthal
Journal:  Am J Med       Date:  1990-03-02       Impact factor: 4.965

Review 3.  Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.

Authors:  K J Holm; K L Goa
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

4.  Standardization in platform stabilometry being a part of posturography.

Authors:  T S Kapteyn; W Bles; C J Njiokiktjien; L Kodde; C H Massen; J M Mol
Journal:  Agressologie       Date:  1983-06

5.  Effects of hypnotics on memory.

Authors:  A Fossen; O B Godlibsen; Y Loyning; J F Dreyfus
Journal:  Pharmacology       Date:  1983       Impact factor: 2.547

6.  Simultaneous screening and quantitative analysis of benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen-phosphorus detection.

Authors:  P Lillsunde; T Seppälä
Journal:  J Chromatogr       Date:  1990-11-30

7.  Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omega receptor subtypes.

Authors:  S Z Langer; S Arbilla
Journal:  Pharmacol Biochem Behav       Date:  1988-04       Impact factor: 3.533

8.  Comparison of the effects of zolpidem and flunitrazepam on sleep structure and daytime cognitive functions. A study of untreated unsomniacs.

Authors:  K Dujardin; J D Guieu; C Leconte-Lambert; P Leconte; P Borderies; B de La Giclais
Journal:  Pharmacopsychiatry       Date:  1998-01       Impact factor: 5.788

Review 9.  Drug treatment as a cause of falls in old age. A review of the offending agents.

Authors:  A J Campbell
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

10.  Effects of zopiclone, triazolam, and nitrazepam on standing steadiness.

Authors:  K Tada; Y Sato; T Sakai; N Ueda; K Kasamo; T Kojima
Journal:  Neuropsychobiology       Date:  1994       Impact factor: 2.328

View more
  19 in total

Review 1.  Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review.

Authors:  Hervé Allain; Danièle Bentué-Ferrer; Elisabeth Polard; Yvette Akwa; Alain Patat
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers.

Authors:  Ian Hindmarch; Eric Legangneux; Neil Stanley; Steve Emegbo; Jean Dawson
Journal:  Br J Clin Pharmacol       Date:  2006-11       Impact factor: 4.335

Review 3.  The effects of fall-risk-increasing drugs on postural control: a literature review.

Authors:  Maartje H de Groot; Jos P C M van Campen; Marije A Moek; Linda R Tulner; Jos H Beijnen; Claudine J C Lamoth
Journal:  Drugs Aging       Date:  2013-11       Impact factor: 3.923

Review 4.  Sleep, cognition, and normal aging: integrating a half century of multidisciplinary research.

Authors:  Michael K Scullin; Donald L Bliwise
Journal:  Perspect Psychol Sci       Date:  2015-01

5.  Use of non-benzodiazepine sedative hypnotics and risk of falls in older men.

Authors:  Susan J Diem; Susan K Ewing; Katie L Stone; Sonia Ancoli-Israel; Susan Redline; Kristine E Ensrud
Journal:  J Gerontol Geriatr Res       Date:  2014-07-01

6.  Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial.

Authors:  Frank A J L Scheer; Christopher J Morris; Joanna I Garcia; Carolina Smales; Erin E Kelly; Jenny Marks; Atul Malhotra; Steven A Shea
Journal:  Sleep       Date:  2012-10-01       Impact factor: 5.849

Review 7.  Zolpidem: a review of its use in the management of insomnia.

Authors:  Tracy Swainston Harrison; Gillian M Keating
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

8.  Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.

Authors:  Geert Mayer; Sherry Wang-Weigand; Barbara Roth-Schechter; Reiner Lehmann; Corinne Staner; Markku Partinen
Journal:  Sleep       Date:  2009-03       Impact factor: 5.849

9.  Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia.

Authors:  Gary Zammit; Milton Erman; Sherry Wang-Weigand; Stephen Sainati; Jeffrey Zhang; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2007-08-15       Impact factor: 4.062

10.  Tolerability, pharmacokinetics and night-time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects.

Authors:  Julia Boyle; Philippe Danjou; Robert Alexander; Nicole Calder; Cynthia Gargano; Nancy Agrawal; Irong Fu; Jacqueline B McCrea; M Gail Murphy
Journal:  Br J Clin Pharmacol       Date:  2008-12-16       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.